{
    "organizations": [],
    "uuid": "b3d3bb266b1f99639782293245cf796672d87afc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-unum-therapeutics-posts-q1-loss-of/brief-unum-therapeutics-posts-q1-loss-of-0-66-per-share-idUSASC0A1W2",
    "ord_in_thread": 0,
    "title": "BRIEF-Unum Therapeutics Posts Q1 Loss Of $0.66 Per Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 14 (Reuters) - Unum Therapeutics Inc:\n* UNUM THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE\n* Q1 LOSS PER SHARE $0.66 * Q1 EARNINGS PER SHARE VIEW $-0.36 â€” THOMSON REUTERS I/B/E/S\n* UNUM THERAPEUTICS - ON TRACK TO FILE IND FOR FIRST SOLID TUMOR PROGRAM, ACTR707 IN COMBINATION WITH TRASTUZUMAB IN 2H 2018\n* AS OF MARCH 31, 2018, UNUM HAD CASH, CASH EQUIVALENTS, AND MARKETABLE SECURITIES OF $32.4 MILLION\n* UNUM - PROCEEDS FROM IPO,CONCURRENT PLACEMENT,EXISTING CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES, WILL FUND EXPENSES THROUGH AT LEAST DEC 2019 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-14T19:17:00.000+03:00",
    "crawled": "2018-05-15T14:00:50.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "unum",
        "therapeutic",
        "inc",
        "unum",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "business",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "unum",
        "therapeutic",
        "track",
        "file",
        "ind",
        "first",
        "solid",
        "tumor",
        "program",
        "actr707",
        "combination",
        "trastuzumab",
        "2h",
        "march",
        "unum",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "million",
        "unum",
        "proceeds",
        "ipo",
        "concurrent",
        "placement",
        "existing",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "fund",
        "expense",
        "least",
        "dec",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}